Further, in a later larger study, Milano et al. concluded that TM6SF2 rs58542926 not only had an impact on liver steatosis, but was also relevant in the development of severe fibrosis in individuals with CHC [22]. This evidence concerns the gene TM6SF2 and fatty liver disease.